[1]
|
Kwak, M.-K., Egner, P.A., Dolan, P.M., Ramos-Gomez, M., Groopman, J.D., Itoh, K., Yamamoto, M. and Kensler, T.W. (2001) Role of Phase 2 Enzyme Induction in Chemoprotection by Dithioethiones. Mutation Research, 480-481, 305-315. http://dx.doi.org/10.1016/S0027-5107(01)00190-7
|
[2]
|
Iyanagi, T. (2007) Molecular Mechanism of Phase I and Phase II Drug-Metabolizing Enzymes: Implications for Detoxification. International Review of Cytology, 260, 35-112. http://dx.doi.org/10.1016/S0074-7696(06)60002-8
|
[3]
|
Nolan, K.A. Timson, D.J., Stratford, I.J. and Bryce, R.A. (2006) In Silico Identification and Biochemical Characterization of Novel Inhibitors of NQO1. Bioorganic & Medicinal Chemistry Letters, 16, 6246-6254. http://dx.doi.org/10.1016/j.bmcl.2006.09.015
|
[4]
|
Dinkova-Kostova, A.T. and Talalay, P. (2010) NAD(P)H:Quinine Acceptor Oxidoreductase 1 (NQO1), a Multifunctional Antioxidant Enzyme and Exceptionally Versatile Cytoprotector. Archives of Biochemistry and Biophysics, 501, 116-123. http://dx.doi.org/10.1016/j.abb.2010.03.019
|
[5]
|
Jancova, P., Anzenbacher, P. and Anzenbacherova, E. (2001) Phase II Drug Metabolizing Enzymes. Biomed. Medical Faculty University Palacky Olomouc Czech Republic, 154, 103-116. http://dx.doi.org/10.5507/bp.2010.017
|
[6]
|
Lu, S.C. (1999) Regulation of Hepatic Glutathione Synthesis: Current Concepts and Controversies. The FASEB Journal, 13, 1169-1183.
|
[7]
|
Suh, J.H., Shenvi, S.V., Dixon, B.M., Liu, H., Jaiswal, A.K., Liu, R.M. and Hagen, T.M. (2004) Decline in Transcriptional Activity of Nrf2 Causes Age-Related Loss of Glutathione Synthesis, Which Is Reversible with Lipoic Acid. Proceedings of the National Academy of Sciences of the United States of America, 101, 3381-3386. http://dx.doi.org/10.1073/pnas.0400282101
|
[8]
|
Shenvi, S.V., Smith, E. and Hagen, T.M. (2012) Identification of Age-Specific Nrf2 Binding to a Novel Antioxidant Response Element Locus in the Gclc Promoter: A Compensatory Means for the Loss of Glutathione Synthetic Capacity in the Aging Rat Liver. Aging Cell, 11, 297-304. http://dx.doi.org/10.1111/j.1474-9726.2011.00788.x
|
[9]
|
Dinkova-Kostova, A.T., Holtzclaw, W.D. and Kensler, T.W. (2005) The Role of Keap1 in Cellular Protective Responses. Chemical Research in Toxicology, 18, 1779-1791. http://dx.doi.org/10.1021/tx050217c
|
[10]
|
Wakabayashi, N., Dinkova-Kostova, A.T., Holtzclaw, W.D., Kang, M.I., Kobayashi, A., Yamamoto, M., Kensler, T. W. and Talalay, P. (2004) Protection against Electrophile and Oxidant Stress by Induction of the Phase 2 Response: Fate of Cysteine of the Keap 1 Sensor Modified by Inducers. Proceedings of the National Academy of Sciences of the United States of America, 101, 2040-2045. http://dx.doi.org/10.1073/pnas.0307301101
|
[11]
|
Owen, J.B. and Butterfield, D.A. (2010) Measurement of Oxidized/Reduced Glutathione Ratio. Methods in Molecular Biology, 648, 269-277. http://dx.doi.org/10.1007/978-1-60761-756-3_18
|
[12]
|
Shapiro, T.A., Fahey, J.W., Wade, K.L., Stephenson, K.K. and Talalay, P. (2001) Chemoprotective Glucosinolates and Isothiocyanates of Broccoli Sprouts: Metabolism and Excretion in Humans. Cancer Epidemiology, Biomarkers & Prevention, 10, 501-508.
|
[13]
|
Emmert, S.W., Desai, D., Amin, S. and Richie Jr., J.P. (2010) Enhanced Nrf2-Dependant Induction of Glutathione in Mouse Embryonic Fibroblasts by Isoselenocyanate Analog of Sulforaphane. Bioorganic & Medicinal Chemistry Letters, 20, 2675-2679. http://dx.doi.org/10.1016/j.bmcl.2010.01.044
|
[14]
|
Fahey, J.W. and Talalay, P. (1999) Antioxidant Functions of Sulforaphane: A Potent Inducer of Phase II Detoxication Enzymes. Food and Chemical Toxicology, 37, 973-979. http://dx.doi.org/10.1016/S0278-6915(99)00082-4
|
[15]
|
Dinkova-Kostova, A.T., Fahey, J.W., Wade, K.L., Jenkins, S.N., Shapiro, T.A., Fuchs, E.J., Kerns, M.L. and Talalay, P. (2007) Induction of the Phase 2 Response in Mouse and Human Skin by Sulforaphane-Containing Broccoli Sprout Extracts. Cancer Epidemiology, Biomarkers & Prevention, 16, 847-851. http://dx.doi.org/10.1158/1055-9965.EPI-06-0934
|
[16]
|
Abel, E.L., Boulware, S., Fields, T., Mclvor, E., Powell, K.L., DiGiovanni, J., Vasquez, K.M. and MacLeod, M.C. (2013) Sulforaphane Induces Phase II Detoxication Enzymes in Mouse Skin and Prevents Mutagenesis Induced by a Mustard Gas Analog. Toxicology and Applied Pharmacology, 266, 439-442. http://dx.doi.org/10.1016/j.taap.2012.11.020
|
[17]
|
Lallemand, B., Chaix, F., Bury, M., Bruyère, C., Ghostin, J., Becker, J.P., Delporte, C., Gelbcke, M., Mathieu, V., Dubois, J., Prévost, M., Jabin, I. and Kiss, R. (2011) N-(2-(3[3,5-bis(trifluoromethyl)phényl]ureido)ethyl)-Glycyrrhetinamide (6b): A Novel Anticancer Glycyrrhetinic Acid Derivative that Targets the Proteasome and Displays Anti-Kinase Activity. Journal of Medicinal Chemistry, 54, 6501-6513. http://dx.doi.org/10.1021/jm200285z
|
[18]
|
Prochaska, H.J. and Santamaria, A.B. (1988) Direct Measurement of NAD(P)H: Quinone Reductase from Cells Cultured in Microtiter Wells: A Screening Assay for Anticarcinogenic Enzyme Inducers. Analytical Biochemistry, 169, 328-336.
|
[19]
|
Ahn, Y.H., Hwang, Y., Liu, H., Wang, X.J., Zhang, Y., Stephenson, K.K., Boronina, T.N., Cole, R.N., Dinkova-Kostova, A.T., Talalay, P. and Cole, P.A. (2010) Electrophilic Tuning of the Chemoprotective Natural Product Sulforaphane. Proceedings of the National Academy of Sciences of the United States of America, 107, 9590-9595. http://dx.doi.org/10.1073/pnas.1004104107
|